Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer

Molecular Carcinogenesis

Volumn 29, Issue 3, 2000, Pages 151-158

  Biéche, Ivan ^a,b   Lidereau, Rosette ^a  

^a CENTRE RENÉ HUGUENIN   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Breast carcinoma; Quantitative reverse transcriptase polymerase chain reaction; RB1

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CHROMOSOME 13; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS INDEX; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0033646933     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200011)29:3<151::AID-MC4>3.3.CO;2-Y     Document Type: Article

References (46)

1. Genetic alterations in breast cancer
2. Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups
3. Molecular cytogenetics of primary breast cancer by CGH
4. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13
5. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors
6. Allelic imbalance on chromosome 13q: Evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer
7. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas
8. Mapping loss of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast tumor progression and poor prognosis
9. The retinoblastoma protein and cell cycle control
10. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
11. Structural rearrangement of the retinoblastoma gene in human breast carcinoma
12. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells
13. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth
14. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours
15. The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene protein expression
16. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study
17. Expression of ras Rb1 and p53 proteins in human breast cancer
18. Retinoblastoma and p53 gene product expression in breast carcinoma: Immunohistochemical analysis and clinicopathologic correlation
19. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival
20. Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues
21. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumour proliferation and oestrogen receptor status
22. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein
23. Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer
24. Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters
25. Wild-type and mutant retinoblastoma protein in paraffin sections
26. Human β-actin retropseudogenes interfere with RT-PCR
27. The presence of a pseudogene may affect the use of HPRT as an endogenous mRNA control in RT-PCR
28. Review: Analogies between trophoblastic and malignant cells
29. Single-step method of RNA isolation by acid guanidium thlocyanate-phenol-chloroform extraction
30. Quantitation of RNA using the polymerase chain reaction
31. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation
32. The 'looped oligo' method for generating reference molecules for quantitative PCR
33. Expression of human chorionic gonadotrophin β subunit genes in superficial and invasive bladder carcinomas
34. Nonparametric estimation from incomplete observations
35. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
36. Quantitation of myc gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
37. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications
38. Role of the retinoblastoma protein in the pathogenesis of human cancer
39. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer
40. Overexpression of BRCA2 gene in sporadic breast tumours
41. Inactivation of the retinoblastoma susceptibility gene in human breast cancer
42. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma
43. Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile
44. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells
45. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence